Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally.
Fair value with moderate growth potential.
Share Price & News
How has Owens & Minor's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: OMI's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: OMI exceeded the US Healthcare industry which returned 1.4% over the past year.
Return vs Market: OMI exceeded the US Market which returned -10.7% over the past year.
Price Volatility Vs. Market
How volatile is Owens & Minor's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StIs Owens & Minor (NYSE:OMI) A Risky Investment?
1 month ago | Simply Wall StInvestors Who Bought Owens & Minor (NYSE:OMI) Shares Five Years Ago Are Now Down 81%
2 months ago | Simply Wall StDoes Owens & Minor, Inc. (NYSE:OMI) Have A Particularly Volatile Share Price?
Is Owens & Minor undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: OMI ($9.15) is trading below our estimate of fair value ($13.47)
Significantly Below Fair Value: OMI is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: OMI is unprofitable, so we can't compare its PE Ratio to the Healthcare industry average.
PE vs Market: OMI is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate OMI's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: OMI is good value based on its PB Ratio (1.2x) compared to the US Healthcare industry average (2.3x).
How is Owens & Minor forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OMI is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.7%).
Earnings vs Market: OMI is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: OMI's is expected to become profitable in the next 3 years.
Revenue vs Market: OMI's revenue is expected to decline over the next 3 years (-2.5% per year).
High Growth Revenue: OMI's revenue is forecast to decline over the next 3 years (-2.5% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: OMI's Return on Equity is forecast to be low in 3 years time (7.8%).
How has Owens & Minor performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: OMI is currently unprofitable.
Growing Profit Margin: OMI is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: OMI is unprofitable, and losses have increased over the past 5 years at a rate of -59.4% per year.
Accelerating Growth: Unable to compare OMI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: OMI is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (14%).
Return on Equity
High ROE: OMI has a negative Return on Equity (-4.89%), as it is currently unprofitable.
How is Owens & Minor's financial position?
Financial Position Analysis
Short Term Liabilities: OMI's short term assets ($2.4B) exceed its short term liabilities ($1.4B).
Long Term Liabilities: OMI's short term assets ($2.4B) exceed its long term liabilities ($1.8B).
Debt to Equity History and Analysis
Debt Level: OMI's debt to equity ratio (338.5%) is considered high.
Reducing Debt: OMI's debt to equity ratio has increased from 61.4% to 338.5% over the past 5 years.
Inventory Level: OMI has a high level of physical assets or inventory.
Debt Coverage by Assets: OMI's debt is covered by short term assets (assets are 1.5x debt).
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: OMI has been profitable on average in the past, therefore cash runway is not a concern.
Forecast Cash Runway: OMI has been profitable on average in the past, therefore cash runway is not a concern.
What is Owens & Minor's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: OMI's dividend (0.11%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.95%).
High Dividend: OMI's dividend (0.11%) is low compared to the top 25% of dividend payers in the US market (5.37%).
Stability and Growth of Payments
Stable Dividend: OMI is not paying a notable dividend for the US market, therefore no need to check if payments are stable.
Growing Dividend: OMI is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: OMI is not paying a notable dividend for the US market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of OMI's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Ed Pesicka (51yo)
Mr. Edward A. Pesicka, also known as Ed, has been the Chief Executive Officer, President and Director of Owens & Minor, Inc. since March 7, 2019. Mr. Pesicka served as Chief Commercial Officer of Thermo Fi ...
CEO Compensation Analysis
Compensation vs Market: Ed's total compensation ($USD5.73M) is above average for companies of similar size in the US market ($USD2.13M).
Compensation vs Earnings: Insufficient data to compare Ed's compensation with company performance.
|Executive VP||4.17yrs||US$1.58m||0.19% $1.1m|
|President of Global Products||1.17yrs||US$1.84m||0.18% $1.0m|
|Executive VP & CFO||0.33yr||no data||0.079% $457.5k|
|Executive VP & Chief Operating Officer||0.33yr||no data||0.079% $457.5k|
|Senior VP||1.75yrs||US$310.84k||0.11% $648.0k|
|Director of Finance & Investor Relations||no data||no data||no data|
|Executive VP & Chief Human Resources Office||2yrs||no data||0.096% $552.7k|
|Executive VP & Chief Commercial Officer||0.67yr||no data||0.079% $457.5k|
|Senior VP & Chief Procurement Officer||0.25yr||no data||no data|
Experienced Management: OMI's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
|Chairman Emeritus||6.92yrs||US$366.50k||no data|
|Chairman Emeritus||no data||US$44.50k||no data|
|Independent Chairman||1.33yrs||US$1.44m||0.23% $1.3m|
|Independent Director||14.92yrs||US$226.25k||0.12% $672.0k|
|Independent Director||2yrs||US$233.75k||0.13% $742.5k|
|Independent Director||0.25yr||US$72.92k||0.012% $67.4k|
|Independent Director||0.42yr||US$122.40k||0.028% $161.9k|
|Independent Director||0.58yr||US$156.25k||0.037% $210.7k|
|Independent Director||no data||no data||0.0056% $32.1k|
Experienced Board: OMI's board of directors are not considered experienced ( 1.2 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Owens & Minor, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Owens & Minor, Inc.
- Ticker: OMI
- Exchange: NYSE
- Founded: 1882
- Industry: Health Care Distributors
- Sector: Healthcare
- Market Cap: US$576.908m
- Shares outstanding: 63.05m
- Website: https://www.owens-minor.com
Number of Employees
- Owens & Minor, Inc.
- 9120 Lockwood Boulevard
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|OMI||NYSE (New York Stock Exchange)||Yes||Common Stock||US||USD||Dec 1972|
|6OM||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Dec 1972|
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; various programs to provide logistics and marketing solutions to its suppliers; and contract logistics services to the pharmaceutical, biotechnology, and medical device industries offering a range of supply chain logistics services to manufacturers. In addition, it offers business services comprising order-to-cash, re-labeling, customer service, and returns management; and warehousing and transportation services consisting of storage, controlled-substance handling, cold-chain, emergency and export delivery, inventory management, and pick and pack services. The Global Products segment manufactures and sources medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. Its products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. The company provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians’ practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is headquartered in Mechanicsville, Virginia.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/04/01 00:12|
|End of Day Share Price||2020/03/31 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.